Browse Related Topics For:

Generic Drugs

97
Pharmaceutical
82
Patents
77
Prescription Drugs
51
SCOTUS
42
FTC
41
FDA
38
Reverse Payment Settlement Agreements
37
ANDA
33
FTC v Actavis
29
Drug Manufacturers
25
Pay-For-Delay
21
Actavis Inc.
19
Pharmaceutical Patents
18
Hatch-Waxman
18
Patent Litigation
17
Preemption
16
Patent Infringement
15
Infringement
13
Design Defects
13
FDCA
11
Settlement
10
Manufacturers
10
Mutual Pharmaceuticals v Bartlett
9
Labeling
8
Antitrust Litigation
8
Medical Devices
8
Watson Pharmaceuticals
7
Healthcare
7
Pharmaceutical Manufacturers
7
Warning Labels
6
Biosimilars
6
Trademarks
5
Biotechnology
5
EU
5
Novartis
4
Appeals
4
China
4
Competition
4
Failure To Warn
4
Mensing
4
Patent Applications
4
PLIVA v Mensing
4
Prior Art
4
Reverse Payments
4
Wyeth
3
Affordable Care Act
3
Anti-Competitive
3
Brand
3
Corporate Counsel
3
Generic
3
GlaxoSmithKline
3
Hoffman LaRoche
3
Liability
3
Merck
3
Obviousness
3
Patent-Eligible Subject Matter
3
Teva Pharmaceuticals
2
Abbott Laboratories
2
Cephalon
2
Claim Construction
2
Drug Safety
2
Eli Lilly
2
European Commission
2
First Sale Doctrine
2
Food Safety
2
GDUFA
2
Google
2
Healthcare Reform
2
HHS
2
Licenses
2
Medicare
2
Misrepresentation
2
Mylan Pharmaceuticals
2
Notice Requirements
2
OIG
2
Pfizer
2
Pharmacies
2
Presumption of Validity
2
Recordkeeping Requirements
2
Rule-of-Reason Analysis
2
Safe Harbors
1
AbbVie
1
Abuse of Dominance
1
Actavis
1
Advertising
1
Alien Tort Statute
1
Ambiguous
1
America Invents Act
1
AMP v Myriad
1
Anti-Kickback Statute
1
Anticompetitive Agreements
1
Approval
1
AstraZeneca
1
Australia
1
Aviation Industry
1
Bad Debt
1
Barack Obama
1
Barclays
1
Bayer
1
Biogen Idec
1
Biologics
1
Biologics Price Competition and Innovation Act of 2009
1
Biopharmaceutical
1
Boeing
1
Bolar Defence
1
Bowman v Monsanto
1
BPCIA
1
Bribery
1
Cadence Pharmaceuticals Inc.
1
Canada
1
Cessna Aircraft Company
1
Charitable PAPs
1
Civil Monetary Penalty
1
Class Action
1
Classen Immunotherapies
1
Clear and Convincing Evidence
1
Clinical Trials
1
CMS
1
Compliance
1
Contraceptive Coverage Mandate
1
Copyright
1
Corruption
1
Cost-Sharing
1
Covenant Not to Sue
1
Covered Business Method Patents
1
CPSC
1
Defect
1
Deficit Reduction
1
Design Patent
1
Dietary Supplements
1
Direct Purchasers
1
Disparagement
1
Doctrine of Equivalents
1
DOJ
1
DQSA
1
Drug Approvals
1
Drug Compounding
1
Drugs
1
Duty to Deal
1
Duty to Train
1
Duty to Warn
1
Edith Ramirez
1
Energy Sector
1
Enforcement
1
Expert Testimony
1
Exports
1
Extraterritoriality Rules
1
FAA
1
False Claims Act
1
Federal Budget
1
Federal Trade Commission Act
1
Fines
1
Food Contamination
1
Food Labeling
1
Forum Non Conveniens
1
FRAND
1
Fraud and Abuse
1
Fraudulent Procurement
1
FTCA
1
Genentech
1
Genetically Engineered Seed
1
Gilead Sciences
1
Honeywell International
1
Hospitals
1
Human Genes
1
Inc v Weeks
1
India
1
Injunctions
1
Innovation
1
Insurers
1
Intent-to-Use
1
Inter Partes Review Proceedings
1
Interest Rates
1
Inventions
1
Irreparable Harm
1
ITC
1
Japan
1
Johnson & Johnson
1
Jon Leibowitz
1
Jury Awards
1
Kirtsaeng v. John Wiley & Sons
1
Laches
1
Lanham Act
1
Libor
1
Life Sciences
1
Loss Causation
1
Marketing
1
Material Defects
1
MD Hellicopters
1
Media
1
Medicaid
1
Medical Device Amendments
1
Medical Research
1
Medicare Advantage
1
Medicare Modernization Act
1
Medicare Part D
1
Medtronics
1
Monopolization
1
Monsanto
1
Mootness
1
Multinationals
1
Myriad
1
Native American Issues
1
New Regulations
1
Nexium
1
Nike
1
Non-Grandfathered Health Plans
1
Nutritional Supplements
1
Octane Fitness v. ICON
1
Online Drug Sales
1
Par/Paddock
1
Patent Exhaustion
1
Patent Reform
1
Patent Term Adjustment
1
Patentability Search
1
Patient Self-Referral
1
Patients
1
Physician Payments
1
Popular
1
Premarket Approval Applications
1
presc
1
Prilosec
1
Proposed Legislation
1
Proposed Regulation
1
Public Performance Rights
1
Putative Class Actions
1
Registration
1
Restraint of Trade
1
Reversal
1
Safety Precautions
1
Sales Contracts
1
Sandoz
1
Schering-Plough
1
SFDA
1
Shell Oil
1
Sherman Act
1
Software
1
Sport
1
Sports
1
Standard of Proof
1
Standing
1
Standing Objections
1
Stem cells
1
Stop-Selling Rationale
1
Structured Financial Products
1
Summary Judgment
1
Supplementary Protection Certificate
1
Textbooks
1
Trade Secrets
1
Transfer of Venue
1
TRIPS Agreement
1
Veterinary Products
1
Walker Process Claims
1
Wireless Devices
1
Women's Preventable Healthcare Mandates
1
Zyprexa